NASDAQ:VYGR Stock Quote

Voyager Therapeutics is a biotechnology company focused on developing innovative gene therapies for neurological diseases

The company utilizes its proprietary adeno-associated viral (AAV) platform to create targeted treatments aimed at addressing disorders such as Parkinson's disease, Huntington's disease, and other neurodegenerative conditions. By leveraging advancements in gene delivery techniques, Voyager Therapeutics aims to provide long-lasting solutions that potentially improve the quality of life for patients suffering from these debilitating illnesses. Their commitment to scientific research and clinical development centers around delivering transformative therapies to address significant unmet medical needs in neurology.